Genenta Science Company Insiders

GNTA Stock  USD 3.72  0.03  0.80%   
Genenta Science employs about 13 people. The company is managed by 8 executives with a total tenure of roughly 31 years, averaging almost 3.0 years of service per executive, having 1.63 employees per reported executive. Analysis of Genenta Science's management performance can provide insight into the company performance.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genenta Science SpA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Genenta Science Management Team Effectiveness

The company has return on total asset (ROA) of (0.3284) % which means that it has lost $0.3284 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5413) %, meaning that it created substantial loss on money invested by shareholders. Genenta Science's management efficiency ratios could be used to measure how well Genenta Science manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.57. In addition to that, Return On Capital Employed is expected to decline to -0.69. At present, Genenta Science's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 19.1 M, whereas Net Tangible Assets are forecasted to decline to about 13.6 M.
As of July 23, 2025, Common Stock Shares Outstanding is expected to decline to about 20 M. In addition to that, Net Loss is expected to decline to about (5.3 M)

Genenta Science Workforce Comparison

Genenta Science SpA is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,686. Genenta Science maintains roughly 13.0 in number of employees contributing less than 1% to equities under Health Care industry.

Genenta Science Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Genenta Science insiders, such as employees or executives, is commonly permitted as long as it does not rely on Genenta Science's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Genenta Science insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Genenta Science Notable Stakeholders

A Genenta Science stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Genenta Science often face trade-offs trying to please all of them. Genenta Science's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Genenta Science's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Pierluigi ParacchiChairman, CoFounderProfile
Stefania MazzoleniDirector DevelopmentProfile
Barbara RegoniniDirector FinanceProfile
Carlo MDChief DevelopmentProfile
Richard SlanskyChief OfficerProfile
Tim ObaraHead DevelProfile
Luigi MDCoFounder BoardProfile
Bernard MDCoFounder BoardProfile

About Genenta Science Management Performance

The success or failure of an entity such as Genenta Science SpA often depends on how effective the management is. Genenta Science management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Genenta management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Genenta management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.60)(0.57)
Return On Capital Employed(0.65)(0.69)
Return On Assets(0.60)(0.57)
Return On Equity(0.66)(0.62)
Please note, the presentation of Genenta Science's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Genenta Science's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Genenta Science's management manipulating its earnings.

Genenta Science Workforce Analysis

Traditionally, organizations such as Genenta Science use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Genenta Science within its industry.

Genenta Science Manpower Efficiency

Return on Genenta Science Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee685.6K
Net Loss Per Executive1.1M
Working Capital Per Employee951.8K
Working Capital Per Executive1.5M

Complementary Tools for Genenta Stock analysis

When running Genenta Science's price analysis, check to measure Genenta Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genenta Science is operating at the current time. Most of Genenta Science's value examination focuses on studying past and present price action to predict the probability of Genenta Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genenta Science's price. Additionally, you may evaluate how the addition of Genenta Science to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities